Sickle Cell Disease

for Health Professionals
See also
Information for Health Consumers
Clinical Practice Guidelines

The IOM (2011) defined clinical practice guidelines as "statements that include recommendations intended to optimize patient care that are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options."

NHLBI Publications and Fact Sheets
RELATED NEWS
Newborn blood spot (heel prick) test (the Guthrie' test). A physician performing the pinprick puncture in one heel of a newborn to collect their blood to screen for inborn errors of metabolism.
|
Research Feature
Rapid Result Test On Track to Transform Sickle Cell Disease Screening for Millions
Soon after birth, a baby in the United States is tested for sickle cell disease, the often-devastating genetic blood disorder affecting more than 100,000 Americans and 20 million of people worldwide. If positive, that newborn typically begins a course of treatment that can greatly prolong life and help stave off complications of the disease. But in sub-Saharan Africa, where the majority of sickle cell disease cases can be found—and where resources are scant—newborn screening programs are virtually non-existent, and as a result, so is treatment that could save lives. Now, research shows that...
RELATED EVENT
Sickle Cell In Focus Conference 2018 Logo
Sickle Cell in Focus Conference 2018
October 22 - 23, 2018
Natcher Conference Center, Ruth L. Kirschstein Auditorium
45 Center Dr., NIH, Bethesda, MD 20894

After an exciting event in Kingston, Jamaica in October 2017, we are thrilled to announce that the 12th annual Sick...